Clinical Trial

The Effect of a Tidal Model-Based Approach Applied During Home Visits on Mental Health Parameters and Hospital Admission Frequency in COPD Patients

Study acronym: Tidal Model
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Despite the recent increased interest in identifying the needs of COPD patients and improving disease management, monitoring the psychosocial well-being of these individuals remains insufficient. Nursing care that incorporates psychosocial approaches plays a critical role in halting disease progression and controlling symptoms in COPD management. The Tidal Model emerges as a vital tool in enhancing patient independence throughout this process. This recovery-oriented model provides a robust framework for individualized care by thoroughly analyzing patients' needs. It likens life to an ocean voyage and emphasizes learning how to cope with challenges encountered during this journey. The difficulties experienced by individuals with chronic illness and respiratory limitations are aligned with the Tidal Model's concepts of chaos and tides. Current studies indicate that psychological interventions for COPD patients have limited effectiveness in reducing psychological morbidity. Additionally, while interventions such as mindfulness-based and digital approaches show promise, their effects have not consistently proven significant across studies. This underscores the ongoing challenge of effectively addressing the psychological aspects of COPD and highlights the need for further research to identify more robust interventions. In this context, guided by the philosophy of the Tidal Model that emphasizes "helping individuals with problems in living," it has been hypothesized that the model would be suitable for use with individuals with COPD. The current study aims to evaluate its effectiveness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-30.
Trial Details
NCT Number NCT06760325
Lead Sponsor Kilis 7 Aralik University
Collaborators: Mersin University
Conditions COPD III/IV
Enrollment 42 participants
Start Date 2024-05-29
Primary Completion 2024-08-29 (estimated)
Study Completion 2025-08-29 (estimated)
Updated on ClinicalTrials.gov 2025-01-08